Greystone Associates

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. For drugs developed for self-administration, autoinjectors have been shown to provide a more user-friendly outer package and improved compliance. While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of prefilled disposable syringes. Until recently, autoinjectors were designed to be reused. The reason was that the injectors were too expensive to be successfully marketed as a throw-away device. Recent improvements in materials technology and device design have led to the creation of a class of autoinjectors that can be made economically in high production quantities, opening the door for the disposable autoinjector, and providing expanded opportunities for both patient and drug marketer.

Publication Date: January 2010

Table of Contents

Text Box: Table of Contents

Executive Summary

Injectable Drug Delivery Market Dynamics

The Economics of Injectable Drugs

What’s Driving the Growth in Autoinjectors?

Prefilled Syringes Proliferating

The Trend toward Self-Administration

Shifting Demographics

Innovation in Disposable Device Designs

Therapeutic Demand Drivers

Competitive Landscape

Risk Factors

Autoinjectors – Commercial Devices

Manual injection Autoinjectors

Automated Injection Autoinjectors

Reusable Autoinjectors

Disposable Autoinjectors

Bundled (Pre-assembled) Autoinjectors

Product Specific Autoinjectors

Novel Autoinjection Feature Designs

Autoinjector Device Design Factors

Material Selection Issues

Part Counts and Device Cost

Safety Features

Needle Shielding

Needle Insertion Depth

Failsafe Activation

Dose Inspection/Injection Confirmation

Lyophilized Drugs/Reconstitution

Human Engineering/Ergonomics

Autoinjector Drug Delivery – Key Therapeutic Sector Analysis

Anemia

Anticoagulants

Autoimmune Diseases

Rheumatoid Arthritis

Multiple Sclerosis

Psoriasis

Diabetes

Emergency Medicine

Hepatitis

Hematopoietics

Hormones

Reproductive Health

Market Factors

Regulatory Issues

Device Branding

Patient Compliance

Healthcare Economics

Ease of Use

Autoinjector Devices - Company Profiles

About Our Reports

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.